Deena Kuruvilla, AHS 2021: External Trigeminal Nerve Stimulator as a Non-pharmacological Option for the Prevention and Acute Treatment of Migraine

touchNEUROLOGY had the pleasure to meet with Deena Kuruvilla (Westport Headache Institute, Westport, CT, USA) to discuss the Cefaly (External Trigeminal Nerve Stimulator) device as a non-pharmacological option for the prevention and acute treatment of migraine.

The abstract ‘A Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)’ was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 June 2021.

Questions:

1. Why is there a need for a non-pharmacological option for the prevention and acute treatment of migraine? (0:20)
2. Could you tell us a little about the Cefaly device and the rationale for its use in this indication? (1:02)
3. What clinical evidence supports the use of the Cefaly device? (1:48)

Disclosures: Deena Kuruvilla is a medical advisor for Cefaly.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Filmed as a highlight of AHS 2021 (Virtual).